CGRP Receptor Antagonists: Toward a Novel Migraine Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|10|1671-1680

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.10, 2011-10, pp. : 1671-1680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine

By Durham Paul L.   Vause Carrie V.  

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 539-548

Adis International

Access to resources Recommend Favorite

CGRP receptor antagonists: an expanding drug class for acute migraine?

By Negro Andrea   Lionetto Luana   Simmaco Maurizio   Martelletti Paolo  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 807-818

Informa Healthcare

Access to resources Recommend Favorite

Substance P receptor antagonists in the therapy of migraine

By May A.   Goadsby P.J.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 673-678

Informa Healthcare

Access to resources Recommend Favorite

CGRP-Receptor Antagonism in Migraine Treatment

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 240-246

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapy in Parkinson's disease: adenosine A2A receptor antagonists

By Szabóó Nikoletta   Kincses Zsigmond Tamáás   Véécsei Láászlóó  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 4, 2011-04 ,pp. : 441-455

Informa Healthcare

Access to resources Recommend Favorite